pemigatinib2022 evaluation

We’d love your feedback A New Treatment Paradigm in Cholangiocarcinoma Pemigatinib Virtual Launch Meeting Your valuable comments help us improve the quality of webinars and we are looking forward to hearing your thoughts. We would appreciate if you could kindly take a few minutes to answer these questions. Thank you very much.

1. How would you rate the topics and the speakers?

Breakthrough in the unmet need of previously treated cholangiocarcinoma with FGFR2 fusions or rearrangements*

Breakthrough in the unmet need of previously treated cholangiocarcinoma with FGFR2 fusions or rearrangements *

Up-to-date & Inspiring	Good Review	Nothing New	Not Relevant
Up-to-date & InspiringUp-to-date & Inspiring	Good ReviewGood Review	Nothing NewNothing New	Not RelevantNot Relevant

Professor Arndt VOGEL *

Excellent	Good	Average	Poor
ExcellentThe topics discussed in this meeting are relevant to my clinical practice Excellent	GoodThe topics discussed in this meeting are relevant to my clinical practice Good	AverageThe topics discussed in this meeting are relevant to my clinical practice Average	PoorThe topics discussed in this meeting are relevant to my clinical practice Poor

Local case sharing *

Up-to-date & Inspiring	Good Review	Nothing New	Not Relevant
Up-to-date & InspiringUp-to-date & Inspiring	Good ReviewGood Review	Nothing NewNothing New	Not RelevantNot Relevant

Dr LAM Ka On *

Excellent	Good	Average	Poor
ExcellentThe topics discussed in this meeting are relevant to my clinical practice Excellent	GoodThe topics discussed in this meeting are relevant to my clinical practice Good	AverageThe topics discussed in this meeting are relevant to my clinical practice Average	PoorThe topics discussed in this meeting are relevant to my clinical practice Poor

Pemigatinib in cholangiocarcinoma with FGFR2 fusions or rearrangements in the Chinese population*

Pemigatinib in cholangiocarcinoma with FGFR2 fusions or rearrangements in the Chinese population *

Up-to-date & Inspiring	Good Review	Nothing New	Not Relevant
Up-to-date & InspiringUp-to-date & Inspiring	Good ReviewGood Review	Nothing NewNothing New	Not RelevantNot Relevant

Professor ZHOU Jian *

Excellent	Good	Average	Poor
ExcellentThe topics discussed in this meeting are relevant to my clinical practice Excellent	GoodThe topics discussed in this meeting are relevant to my clinical practice Good	AverageThe topics discussed in this meeting are relevant to my clinical practice Average	PoorThe topics discussed in this meeting are relevant to my clinical practice Poor

2. Which part of today’s webinar was most useful to you?

3. Any other topics / areas that you would have liked to be included?

4. What improvements can be made to the webinar?

Name

First

Last

For CME purpose

Location